Articles published by ResMed Inc.
ResMed Announces Participation in the UBS Global Healthcare Conference
November 05, 2024
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
September 30, 2024
From ResMed Inc.
Via GlobeNewswire
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
September 10, 2024
From ResMed Inc.
Via GlobeNewswire
Vaping Expected to Increase COPD Health and Economic Burden by 2050
September 10, 2024
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From ResMed Inc.
Via GlobeNewswire
From ResMed Inc.
Via GlobeNewswire
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
December 07, 2023
From ResMed Inc.
Via GlobeNewswire
ResMed Adopts New Operating Model to Accelerate Long-term Growth
November 09, 2023
From ResMed Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.